Literature DB >> 18692077

The MBD protein family-reading an epigenetic mark?

Archana Dhasarathy1, Paul A Wade.   

Abstract

A family of proteins conserved throughout the eukaryotic lineage is characterized by the presence of a common sequence motif-the methyl-CpG-binding domain, or MBD. This sequence motif corresponds to a structural domain which, in some but not all cases, confers the ability to bind methylated cytosine residues in the context of the dinucleotide 5' CG 3'. Mammals have five well-characterized members of this family, each with unique biological characteristics. Recently, much progress has been made in defining the biochemical properties of one member of this family, MeCP2. This protein has a very high affinity for chromatin and considerable insight has been gained into its interactions with naked DNA and with chromatin fibers. Previous models have proposed that several members of the MBD family contribute to establishment and/or maintenance of transcriptional repression by recruiting enzymes that locally modify histones. Surprisingly, recent data indicate that MeCP2 is likely to contribute to chromatin properties through an architectural role, participating in higher order chromatin structures that facilitate both gene repression as well as gene activation. These observations suggest that existing models probably do not explain the entire gamut of biological functions performed by this very interesting protein family.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18692077      PMCID: PMC2670759          DOI: 10.1016/j.mrfmmm.2008.07.007

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  36 in total

Review 1.  Methylation-induced repression--belts, braces, and chromatin.

Authors:  A P Bird; A P Wolffe
Journal:  Cell       Date:  1999-11-24       Impact factor: 41.582

2.  Active repression of methylated genes by the chromosomal protein MBD1.

Authors:  H H Ng; P Jeppesen; A Bird
Journal:  Mol Cell Biol       Date:  2000-02       Impact factor: 4.272

3.  DNA binding selectivity of MeCP2 due to a requirement for A/T sequences adjacent to methyl-CpG.

Authors:  Robert J Klose; Shireen A Sarraf; Lars Schmiedeberg; Suzanne M McDermott; Irina Stancheva; Adrian P Bird
Journal:  Mol Cell       Date:  2005-09-02       Impact factor: 17.970

4.  Testing for association between MeCP2 and the brahma-associated SWI/SNF chromatin-remodeling complex.

Authors:  Keping Hu; Xinsheng Nan; Adrian Bird; Weidong Wang
Journal:  Nat Genet       Date:  2006-09       Impact factor: 38.330

5.  Multiple modes of interaction between the methylated DNA binding protein MeCP2 and chromatin.

Authors:  Tatiana Nikitina; Xi Shi; Rajarshi P Ghosh; Rachel A Horowitz-Scherer; Jeffrey C Hansen; Christopher L Woodcock
Journal:  Mol Cell Biol       Date:  2006-11-13       Impact factor: 4.272

6.  Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2.

Authors:  R E Amir; I B Van den Veyver; M Wan; C Q Tran; U Francke; H Y Zoghbi
Journal:  Nat Genet       Date:  1999-10       Impact factor: 38.330

7.  Regulation of RNA splicing by the methylation-dependent transcriptional repressor methyl-CpG binding protein 2.

Authors:  Juan I Young; Eugene P Hong; John C Castle; Juan Crespo-Barreto; Aaron B Bowman; Matthew F Rose; Dongcheul Kang; Ron Richman; Jason M Johnson; Susan Berget; Huda Y Zoghbi
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-26       Impact factor: 11.205

8.  Intrinsic disorder and autonomous domain function in the multifunctional nuclear protein, MeCP2.

Authors:  Valerie H Adams; Steven J McBryant; Paul A Wade; Christopher L Woodcock; Jeffrey C Hansen
Journal:  J Biol Chem       Date:  2007-03-19       Impact factor: 5.157

9.  Solution structure of the methyl-CpG-binding domain of the methylation-dependent transcriptional repressor MBD1.

Authors:  I Ohki; N Shimotake; N Fujita; M Nakao; M Shirakawa
Journal:  EMBO J       Date:  1999-12-01       Impact factor: 11.598

10.  The solution structure of the domain from MeCP2 that binds to methylated DNA.

Authors:  R I Wakefield; B O Smith; X Nan; A Free; A Soteriou; D Uhrin; A P Bird; P N Barlow
Journal:  J Mol Biol       Date:  1999-09-03       Impact factor: 5.469

View more
  47 in total

Review 1.  Epigenetic effects of endocrine-disrupting chemicals on female reproduction: an ovarian perspective.

Authors:  Aparna Mahakali Zama; Mehmet Uzumcu
Journal:  Front Neuroendocrinol       Date:  2010-07-04       Impact factor: 8.606

Review 2.  Child health, developmental plasticity, and epigenetic programming.

Authors:  Z Hochberg; R Feil; M Constancia; M Fraga; C Junien; J-C Carel; P Boileau; Y Le Bouc; C L Deal; K Lillycrop; R Scharfmann; A Sheppard; M Skinner; M Szyf; R A Waterland; D J Waxman; E Whitelaw; K Ong; K Albertsson-Wikland
Journal:  Endocr Rev       Date:  2010-10-22       Impact factor: 19.871

Review 3.  Epigenetic responses to environmental change and their evolutionary implications.

Authors:  Bryan M Turner
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2009-11-27       Impact factor: 6.237

4.  Loss of methyl-CpG-binding domain protein 2 enhances endothelial angiogenesis and protects mice against hind-limb ischemic injury.

Authors:  Xiaoquan Rao; Jixin Zhong; Shu Zhang; Yushan Zhang; Qilin Yu; Ping Yang; Mong-Heng Wang; David J Fulton; Huidong Shi; Zheng Dong; Daowen Wang; Cong-Yi Wang
Journal:  Circulation       Date:  2011-06-13       Impact factor: 29.690

5.  Overexpression of methyl-CpG binding protein 2 impairs T(H)1 responses.

Authors:  Tianshu Yang; Melissa B Ramocki; Jeffrey L Neul; Wen Lu; Luz Roberts; John Knight; Christopher S Ward; Huda Y Zoghbi; Farrah Kheradmand; David B Corry
Journal:  Sci Transl Med       Date:  2012-12-05       Impact factor: 17.956

6.  HOXB13, a target of DNMT3B, is methylated at an upstream CpG island, and functions as a tumor suppressor in primary colorectal tumors.

Authors:  Kalpana Ghoshal; Tasneem Motiwala; Rainer Claus; Pearlly Yan; Huban Kutay; Jharna Datta; Sarmila Majumder; Shoumei Bai; Arnab Majumder; Tim Huang; Christoph Plass; Samson T Jacob
Journal:  PLoS One       Date:  2010-04-29       Impact factor: 3.752

7.  Expanding the landscape of chromatin modification (CM)-related functional domains and genes in human.

Authors:  Shuye Pu; Andrei L Turinsky; James Vlasblom; Tuan On; Xuejian Xiong; Andrew Emili; Zhaolei Zhang; Jack Greenblatt; John Parkinson; Shoshana J Wodak
Journal:  PLoS One       Date:  2010-11-29       Impact factor: 3.240

8.  Epigenetic silencing of peroxisome proliferator-activated receptor γ is a biomarker for colorectal cancer progression and adverse patients' outcome.

Authors:  Massimo Pancione; Lina Sabatino; Alessandra Fucci; Vincenzo Carafa; Angela Nebbioso; Nicola Forte; Antonio Febbraro; Domenico Parente; Concetta Ambrosino; Nicola Normanno; Lucia Altucci; Vittorio Colantuoni
Journal:  PLoS One       Date:  2010-12-03       Impact factor: 3.240

9.  Do different neurons age differently? Direct genome-wide analysis of aging in single identified cholinergic neurons.

Authors:  Leonid L Moroz; Andrea B Kohn
Journal:  Front Aging Neurosci       Date:  2010-05-19       Impact factor: 5.750

Review 10.  DNA methylation and methyl-CpG binding proteins: developmental requirements and function.

Authors:  Ozren Bogdanović; Gert Jan C Veenstra
Journal:  Chromosoma       Date:  2009-06-09       Impact factor: 4.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.